FAZIOLI, Francesca
 Distribuzione geografica
Continente #
NA - Nord America 5.749
EU - Europa 3.282
AS - Asia 1.844
SA - Sud America 371
AF - Africa 141
Continente sconosciuto - Info sul continente non disponibili 87
OC - Oceania 12
Totale 11.486
Nazione #
US - Stati Uniti d'America 5.575
RU - Federazione Russa 1.585
SG - Singapore 558
VN - Vietnam 435
IT - Italia 415
BR - Brasile 302
CN - Cina 293
UA - Ucraina 272
HK - Hong Kong 204
SE - Svezia 196
DE - Germania 181
IE - Irlanda 152
FR - Francia 108
CA - Canada 105
DK - Danimarca 103
TR - Turchia 94
CI - Costa d'Avorio 89
GB - Regno Unito 84
FI - Finlandia 80
KR - Corea 57
BD - Bangladesh 41
IN - India 34
AR - Argentina 29
NL - Olanda 29
MX - Messico 26
JP - Giappone 21
BE - Belgio 19
ZA - Sudafrica 15
IQ - Iraq 13
PL - Polonia 13
CO - Colombia 12
ID - Indonesia 11
AT - Austria 10
PH - Filippine 10
SA - Arabia Saudita 10
CL - Cile 9
CR - Costa Rica 9
MA - Marocco 8
NZ - Nuova Zelanda 8
DZ - Algeria 7
EC - Ecuador 7
HN - Honduras 7
VE - Venezuela 7
AE - Emirati Arabi Uniti 6
ES - Italia 6
PK - Pakistan 6
SV - El Salvador 6
UZ - Uzbekistan 6
IL - Israele 5
JM - Giamaica 5
JO - Giordania 5
LT - Lituania 5
RS - Serbia 5
SY - Repubblica araba siriana 5
TT - Trinidad e Tobago 5
AU - Australia 4
CZ - Repubblica Ceca 4
ET - Etiopia 4
OM - Oman 4
SC - Seychelles 4
TH - Thailandia 4
AZ - Azerbaigian 3
CH - Svizzera 3
EG - Egitto 3
EU - Europa 3
GT - Guatemala 3
KE - Kenya 3
KZ - Kazakistan 3
MY - Malesia 3
PR - Porto Rico 3
PY - Paraguay 3
RO - Romania 3
TN - Tunisia 3
A2 - ???statistics.table.value.countryCode.A2??? 2
HR - Croazia 2
NG - Nigeria 2
NI - Nicaragua 2
NP - Nepal 2
PS - Palestinian Territory 2
TW - Taiwan 2
AL - Albania 1
AM - Armenia 1
AO - Angola 1
BB - Barbados 1
BG - Bulgaria 1
BH - Bahrain 1
BS - Bahamas 1
CG - Congo 1
CW - ???statistics.table.value.countryCode.CW??? 1
CY - Cipro 1
EE - Estonia 1
GY - Guiana 1
HU - Ungheria 1
IR - Iran 1
KG - Kirghizistan 1
LB - Libano 1
LK - Sri Lanka 1
LV - Lettonia 1
MC - Monaco 1
MD - Moldavia 1
Totale 11.402
Città #
Dallas 1.481
Ashburn 578
Chandler 352
Singapore 331
Des Moines 290
Jacksonville 270
San Jose 195
Hong Kong 192
Boardman 161
Fairfield 159
Council Bluffs 157
Ho Chi Minh City 155
Dublin 151
New York 132
Ann Arbor 120
Hanoi 94
Wilmington 90
Abidjan 89
Houston 87
Woodbridge 85
Beijing 77
Princeton 73
Los Angeles 70
The Dalles 69
Seattle 61
Lawrence 59
San Mateo 57
Lauterbourg 54
Cambridge 53
Milan 50
Moscow 49
Hefei 44
São Paulo 36
Centro 33
Marche 31
Ottawa 28
Munich 27
Turin 25
Buffalo 21
Da Nang 21
Helsinki 21
Redmond 20
Brussels 19
Rome 19
Santa Clara 19
Phoenix 18
Haiphong 17
Orem 17
San Diego 17
Alton 16
Montreal 16
Ancona 15
Chicago 15
Tokyo 15
London 13
Poplar 13
Toronto 13
Guangzhou 11
Warsaw 11
Washington 11
Boston 10
Columbus 10
Denver 10
Tampa 10
Atlanta 9
Brooklyn 9
Chennai 9
Mexico City 9
Nuremberg 9
Salt Lake City 9
Brasília 8
Dhaka 8
Manchester 8
Turku 8
Belo Horizonte 7
Chelsea 7
Curitiba 7
Elk Grove Village 7
Frankfurt am Main 7
Hải Dương 7
Miami 7
Naples 7
Norwalk 7
Porto Alegre 7
Wuhan 7
Biên Hòa 6
Jakarta 6
Johannesburg 6
Padova 6
Ribeirão Preto 6
San Francisco 6
San José 6
San Salvador 6
Shanghai 6
Tashkent 6
Trieste 6
Amman 5
Amsterdam 5
Bogotá 5
Can Tho 5
Totale 6.712
Nome #
110 SERUM LEVELS OF UROKINASE-TYPE PLASMINOGEN ACTIVATOR RECEPTOR AND EPIDERMAL GROWTH FACTOR RECEPTOR IN PATIENTS WITH PROSTATE CANCER AND BENIGN PROSTATIC HYPERPLASIA 2.246
Circulating inflamma-miRs in aging and age-related diseases. 819
Circulating Inflamma-miRs as Potential Biomarkers of Cognitive Impairment in Patients Affected by Alzheimer's Disease 245
Cytotoxic and genotoxic potential of asbestos fibers from environmental outcrops 229
Cytotoxicity in vitro of two non-commercial samples of chrysotile and fibrous erionite 224
Analysis of M1 and M2 tumor associated macrophages in tongue squamous cell carcinomas. 221
Activation of transcription factors STAT1 and STAT5 in the mouse median eminence after systemic ciliary neurotrophic factor administration 211
Differences in survivin localization and Bcl-2 expression in CD30+ lymphoproliferative disorderd of the skin compared to systemic anaplastic large cell lymphomas: an immunohistochemical study 209
In Vitro H2O2 Stress And Patterns Of Mitochondrial Damage In The Nctc 2544 Continuous Cell Line 209
Fisiopatologia degli organi emopoietici e del sangue 192
A new germline point mutation in Ret exon 8 (cys515ser) in a family with medullary thyroid carcinoma 185
Prognostic Relevance of Macrophage Phenotypes in High-grade Oral Tongue Squamous Cell Carcinomas 176
Biosynthesis and apical localization of the urokinase receptor in polarized MDCK epithelial cells. 171
Asbestos induced toxicity: in vitro different effects of different fibres. 170
A ligand-inducible anaplastic lymphoma kinase chimera is endocytosis impaired 168
Identification and biochemical characterization of novel putative substrates for the epidermal growth factor receptor kinase. 161
Plasma levels of interleukin-38 in healthy aging and in type 2 diabetes 159
Low FasL levels promote proliferation of human bone marrow-derived mesenchymal stem cells, higher levels inhibit their differentiation into adipocytes. 156
Activation of alpha-diacylglycerol kinase is critical for the mitogenic properties of anaplastic lymphoma kinase 156
Absence of somatic mutations in natriuretic peptide receptor type A gene in human aldosterone-secreting adenomas 154
The carboxy-terminal domains of erbB-2 and epidermal growth factor receptor exert different regulatory effects on intrinsic receptor tyrosine kinase function and transforming activity. 153
The Experimental Pathology at Ancona: 50 Years of Exciting and Pioneering Research on Human Pathology 150
Eps8, a substrate for the epidermal growth factor receptor kinase, enhances EGF-dependent mitogenic signals. 149
A urokinase-sensitive region of the human urokinase receptor is responsible for its chemotactic activity. 145
Integrin-dependent induction of functional urokinase receptors in primary T lymphocytes. 145
Constitutive expression of IL-1 beta, M-CSF and c-fms during the myeloid blastic phase of chronic myelogenous leukaemia. 144
miR-132–3p is down-regulated in plasma and CD171+ extracellular vesicles isolated from patients with mild Alzheimer’s disease 141
The juxtamembrane regions of the epidermal growth factor receptor and gp185erbB-2 determine the specificity of signal transduction. 141
A paracrine circuit in the regulation of the proliferation of macrophages infiltrating murine sarcomas. 140
erbB-2 autophosphorylation is required for mitogenic action and high-affinity substrate coupling. 139
Sex/gender-related differences in inflammaging 135
Proteolytic cleavage of the urokinase receptor substitutes for the agonist-induced chemotactic effect. 135
Analisys of Y-linked microdeletions in idiopathic oligo- and azoospermic patients 133
Cancerogenesi chimica e fisica 133
77 Soluble urokinase receptor expression in urine is a prognostic marker in patients with transitional cell carcinoma of the bladder 130
Prognostic value analysis of urokinase-type plasminogen activator receptor in oral squamous cell carcinoma: an immunohistochemical study. 128
eps15, a novel tyrosine kinase substrate, exhibits transforming activity. 127
Expression of Met protein and urokinase-type plasminogen activator receptor (uPA-R) in papillary carcinoma of the thyroid. 126
Coenzyme Q10 levels in idiopathic and varicocele-associated asthenozoospermia 126
Removal of domain D2 or D3 of the human urokinase receptor does not affect ligand affinity. 125
A ligand-inducible epidermal growth factor receptor/anaplastic lymphoma kinase chimera promotes mitogenesis and transforming properties in 3T3 cells 125
Immunohistochemical evaluation of urokinase plasminogen activator receptor in noninvasive and early invasive urothelial papillary neoplasia. 123
Direct binding of eps8 to the juxtamembrane domain of EGFR is phosphotyrosine- and SH2-independent. 120
Bridging the gap between toxicity and carcinogenicity of mineral fibres by connecting the fibre parameters to the key characteristics of carcinogens: a comprehensive model inspiring asbestos-induced cancer prevention strategies 119
Expression of growth hormone-releasing hormone receptor splicing variants in human primary adrenocortical tumours 118
The Pro/Pro genotype of the p53 codon 72 polymorphism modulates PAI-1 plasma levels in ageing. 115
Evaluation of epidermal growth factor receptor and urokinase-type plasminogen activator receptor in serum of prostate cancer patients 113
Polynucleotide and substrate for the epidermal growth factor receptor kinase (EPS8) 112
DNA encoding human and murine EPS15, a substrate for the epidermal growth factor receptor 109
Increased urokinase-type plasminogen activator receptor and epidermal growth factor receptor in serum of patients with prostate cancer 104
uPAR mimicking peptides 101
In Vitro H202 stress and patterns of mitochondrial damage in the NCTC 2544 Continuous cell line- a morphological and morphometric study. 101
Serum soluble urokinase-type plasminigen activator receptor (Supar) is a useful marker of prostate cancer 100
SERUM SOLUBLE UROKINASE-TYPE PLASMINOGEN ACTIVATOR RECEPTOR (SUPAR) IS A USEFUL MARKER OF PROSTATE CANCER 94
Evaluation of epidermal growth factor receptor and urokinase-type plasminogen activator receptor in serum of prostate cancer patients 94
Survivin detection in saliva samples from patient with oral squamous cell carcinoma 93
Levels of urokinase-type plasminogen activator receptor inserum and urine of bladder cancer patients. Preliminaryresults 87
The erbB-2 mitogenic signaling pathway: tyrosine phosphorylation of phospholipase C-gamma and GTPase-activating protein does not correlate with erbB-2 mitogenic potency. 81
Src-dependence and pertussis-toxin sensitivity of urokinase receptor-dependent chemotaxis and cytoskeleton reorganization in rat smooth muscle cells 80
Purification of tyrosine phosphorylated proteins by immunoaffinity chromatography and direct cloning of their cDNAs from bacterial expression libraries 79
Urokinase-type plasminogen activator and its receptor: new targets for anti-metastatic therapy? 72
PPARγ expression in normal human placenta, hydatidiform mole and choriocarcinoma 71
The ezrin-like family of tyrosine kinase substrates: receptor-specific pattern of tyrosine phosphorylation and relationship to malignant transformation. 69
Totale 11.486
Categoria #
all - tutte 37.819
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 37.819


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022313 0 0 0 0 10 32 18 36 33 41 52 91
2022/20231.183 78 109 80 98 83 357 2 63 220 6 61 26
2023/2024590 89 15 35 99 93 123 9 14 2 28 15 68
2024/20251.148 163 87 68 8 47 24 121 59 227 120 103 121
2025/20265.605 248 562 1.128 319 272 233 624 264 1.525 203 119 108
2026/2027731 138 119 143 307 24 0 0 0 0 0 0 0
Totale 11.486